CAT
Caterpillar Inc.
CAT's fundamentals are strong, but it looks expensive: trading at 24x earnings, above its usual 18x. Analysts expect strong earnings growth, though they disagree widely on how much.
IPWR
Ideal Power Inc.
There isn't enough reported data to score IPWR yet.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
IPWR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Unavailable |
IPWR's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | โ |
| Current | 24x | $605 | โ |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
IPWR PE Valuation
IPWR has no meaningful PE right now: it lost money over the past year.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
IPWR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect IPWR's losses to shrink, with revenue growing.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over IPWR on earnings quality, reporting a profit while its opponent remains loss making.
IPWR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.06 | +$0.20 |
| Q1 2026 | -$1.19 | +$0.05 |
| Q4 2025 | -$1.16 | +$0.17 |
| Q3 2025 | -$1.27 | +$0.13 |
| Q2 2025 | -$1.26 | +$0.27 |
| Q1 2025 | -$1.24 | +$0.35 |
| Q4 2024 | -$1.33 | +$0.28 |
| Q3 2024 | -$1.40 | +$0.13 |
IPWR is still losing money, but far less than before: $1.06 per share over the past year, against $3.46 at its worst in late 2019.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over IPWR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over IPWR on profitability, with a higher operating margin.
IPWR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $5.8K | +355% |
| Q3 2025 | $24.5K | +4313% |
| Q2 2025 | $1.3K | -4.2% |
| Q1 2025 | $12K | -85% |
| Q4 2024 | $5.4K | -91% |
| Q3 2024 | $554 | -64% |
| Q2 2024 | $1.3K | -99% |
| Q4 2023 | $61.5K | +270% |
IPWR's revenue is recovering but still below its 2020 peak: $5,800 last quarter, up 355% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -62468% | +183845 points |
| Q3 2025 | -12353% | +511046 points |
| Q2 2025 | -246313% | -29483 points |
| Q1 2025 | -23534% | -20325 points |
| Q4 2024 | -51009% | -46968 points |
| Q3 2024 | -523399% | -341013 points |
| Q2 2024 | -216830% | -215064 points |
| Q1 2024 | -3209% | N/A |
IPWR's operating margin was โ62468% last quarter, down 11459 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over IPWR on cash generation, producing positive trailing cash flow while its opponent burns cash.
IPWR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.4M | -$59.6K |
| Q1 2026 | -$2.2M | -$98.9K |
| Q4 2025 | -$2.2M | +$383.3K |
| Q3 2025 | -$2.6M | -$267K |
| Q2 2025 | -$2.4M | -$258.3K |
| Q1 2025 | -$2.1M | -$173.2K |
| Q4 2024 | -$2.6M | -$558.3K |
| Q3 2024 | -$2.4M | -$496.6K |
IPWR has burned cash in almost every quarter: โ$9M over the past year, against โ$9M the year before.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
IPWR Net Leverage
IPWR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
IPWR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 5.3 | Oversold |
IPWR's weekly RSI is 33 (neutral) and its Stochastic is 5 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
IPWR PE vs Industrials Sector
IPWR has no meaningful PE right now: it lost money over the past year.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over IPWR on trend strength, trading above more of its moving averages.
IPWR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.03 | 28% below |
| 20 week MA | $3.92 | 44% below |
| 50 week MA | $4.08 | 46% below |
| 100 week MA | $4.76 | 54% below |
| 200 week MA | $6.92 | 68% below |
IPWR is in a downtrend: it's below all five of its weekly moving averages, and 68% below its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over IPWR on returns for 2026, with the stronger performance.
IPWR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.24 | $9.90 | +342% |
| 2021 | $9.90 | $10.3 | +4.3% |
| 2022 | $10.3 | $11.7 | +13% |
| 2023 | $11.7 | $7.77 | -33% |
| 2024 | $7.77 | $7.54 | -3% |
| 2025 | $7.54 | $3.24 | -57% |
| 2026 YTD | $3.24 | $2.19 | -32% |
IPWR has finished three years in a row lower, and it's down 32% so far in 2026.